DPYSL4 was exclusively upregulated in the siPFKBF4 100 nM/DOX group as an apoptotic agent compared to downregulation in other monotherapy groups, indicating synergistic effects of siRNA and chemotherapy against tumor growth and invasion. This evidence concerns the gene DPYSL4 and neoplasm.